Parallax Health Sciences Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 128,600 compared to USD 11,739 a year ago. Operating loss was USD 6.393 million compared to USD 6.634 million a year ago. Net loss was USD 12.866 million compared to net income of USD 14.783 million a year ago. Basic loss per share from continuing operations was USD 0.064 compared to basic earnings per share from continuing operations of USD 0.105 a year ago. Diluted loss per share from continuing operations was USD 0.049 compared to diluted earnings per share from continuing operations of USD 0.072 a year ago.